The technologies described in this briefing are artificial intelligence (AI) technologies for chest CT. They are used for assisting with triaging, reporting, and identifying abnormalities.
The innovative aspects are that the software helps radiologists and radiographers detect abnormalities in chest CT images.
The intended place in therapy would be to support radiologists and radiographers when reviewing chest CT images in secondary care for people who have been referred for chest CT.
The main points from the evidence summarised in this briefing are from 2 retrospective studies. The best quality evidence came from 1 UK study showing that Veye Chest (Aidence) performed similarly to chest radiologists for lung nodule segmentation growth assessment. The studies were limited in quality and no studies were published in full.